[1]
Coates, L., Gladman, D., Nash, P., FitzGerald, O., Kavanaugh, A., Rasouliyan, L., Pricop, L., Ding, K. and Gaillez, C. 2018. Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S17. DOI:https://doi.org/10.25251/skin.2.supp.17.